What is our Investment Case?
In becoming the trusted global leader in access to medicines, the Group has consistently delivered healthy financial performances and returns. Below are the reasons to invest in Clinigen.
We offer access to medicines at all stages of the pharmaceutical product lifecycle, utilising operational synergies across the services and products divisions
We have built a global supply chain and distribution network, organically, through acquisitions and partnerships, providing local market knowledge supported by global expertise, supplying into over 100 countries
We are the market-leader in CTS and Unlicensed Medicines
We are experts in the supply and distribution of unlicensed medicines
We have an experienced and diverse Group and regional management, with a track record of delivering strong growth every year since inception
The business can grow both through organic growth, with an increasing exposure to emerging pharmaceutical growth markets and through acquisition
We have deep well-established relationships with pharmaceutical companies
We generate strong cash returns which are underpinned by strong credit control and working capital management